Annual Renewal Assessment of Comirnaty Marketing Authorisation
Reference: European Medicines Agency (2021). Assessment report on the annual renewal of the conditional marketing authorisation for Comirnaty (COVID-19 mRNA vaccine). EMA/596333/2021. Summary: The European Medicines Agency (EMA) conducted an assessment for the annual renewal of the conditional marketing authorisation (CMA) for Comirnaty, a COVID-19 mRNA vaccine developed by BioNTech. Originally granted on 21 December […]